Fractyl Health, Inc. Common Stock
General ticker "GUTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $86.2M (TTM average)
Fractyl Health, Inc. Common Stock does not follow the US Stock Market performance with the rate: -6.9%.
Estimated limits based on current volatility of 3.0%: low 0.75$, high 0.80$
Factors to consider:
- Total employees count: 102 as of 2023
- Top business risk factors: Limited operating history, Clinical trial failure, Regulatory and compliance, Manufacturing risks, Going concern doubt
- Current price 41.0% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.37$, 3.86$]
- 2026-12-31 to 2027-12-31 estimated range: [1.11$, 3.21$]
Short-term GUTS quotes
Long-term GUTS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.12MM | $0.09MM | $0.00MM |
| Operating Expenses | $50.96MM | $93.62MM | $96.82MM |
| Operating Income | $-50.84MM | $-93.53MM | $-96.82MM |
| Non-Operating Income | $-26.25MM | $24.84MM | $-44.14MM |
| R&D Expense | $38.04MM | $70.47MM | $74.54MM |
| Income(Loss) | $-77.09MM | $-68.69MM | $-140.95MM |
| Net Income(Loss)* | $-77.09MM | $-68.69MM | $-140.95MM |
| Stockholders Equity | $-325.06MM | $28.42MM | $9.46MM |
| Inventory | $0.07MM | $0.07MM | $0.00MM |
| Assets | $76.21MM | $108.08MM | $121.40MM |
| Operating Cash Flow | $-42.82MM | $-65.52MM | $-90.33MM |
| Capital expenditure | $0.36MM | $1.76MM | $0.56MM |
| Investing Cash Flow | $-0.36MM | $-1.76MM | $-0.56MM |
| Financing Cash Flow | $27.44MM | $101.23MM | $104.96MM |
| Earnings Per Share** | $-1.62 | $-1.58 | $-1.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.